Chronic (-)baclofen or CGP 36742 alters GABAB receptor sensitivity in rat brain and spinal cord

Neuroreport. 1995 Jan 26;6(2):399-403. doi: 10.1097/00001756-199501000-00042.

Abstract

Administration of the GABAB receptor agonist, (-)-baclofen 10 mg kg-1, i.p. daily for 21 days to rats prevented (-)-baclofen-induced hyperpolarizing responses and synaptically-evoked late inhibitory potentials (IPSPs) in olfactory cortical neurones recorded intracellularly from 450 microns brain slices. In contrast, pre-treatment with CGP 36742 induced a significant increase in (-)-baclofen-mediated post-synaptic responses and late IPSP amplitude. In the spinal cord, the potency of (-)-baclofen in inhibiting electrically-evoked substance P-like immunoreactivity or amino acid release was significantly reduced or increased in slices from rats pre-treated with the GABAB agonist or antagonist, respectively. These data suggest that functional responses to GABAB receptor activation in the mammalian central nervous system can be up- or down-regulated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / metabolism
  • Analysis of Variance
  • Animals
  • Baclofen / pharmacology*
  • Evoked Potentials / drug effects
  • Immunohistochemistry
  • In Vitro Techniques
  • Male
  • Membrane Potentials / drug effects
  • Neuronal Plasticity / drug effects*
  • Olfactory Pathways / drug effects*
  • Olfactory Pathways / metabolism
  • Organophosphorus Compounds / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, GABA-B / drug effects*
  • Spinal Cord / drug effects*
  • Spinal Cord / metabolism
  • Substance P / analysis

Substances

  • Amino Acids
  • Organophosphorus Compounds
  • Receptors, GABA-B
  • (3-aminopropyl)(n-butyl)phosphinic acid
  • Substance P
  • Baclofen